TREXA
10 MG · tablet · box of 15
METHOTREXATEHistorical reference: this presentation is not marketed, withdrawn or suspended according to the source. Its listed price does not establish availability.
Reference dated : 2026-10-01. Confirm price and availability with a pharmacist.
Public price
49,10 MAD
Laboratory
BOTTU
What is this medicine?
French reference leaflet: METHOTREXATE ACCORD 10 mg, comprimé. Confirm indications in Morocco with a pharmacist.
Pharmacotherapeutic class: other immunosuppressants - ATC code: L04AX03. METHOTREXATE ACCORD 10 mg, tablet contains methotrexate as the active substance. Methotrexate is an antimetabolite and an immunosuppressant (a medicine that affects the reproduction of the body's cells and reduces the activity of the immune system). Methotrexate is used in the treatment of: · rheumatoid arthritis in adults, · severe psoriasis, particularly plaque psoriasis, in patients who have tried other treatments and these have not improved their disease, · active psoriatic arthritis in adult patients, · acute lymphoblastic leukemia (ALL) in adults, adolescents and children aged at least 3 years. Your doctor may explain to you how METHOTREXATE ACCORD can help relieve the condition you suffer from.
Full clinical reference
Additional sections are available in French. Read the original document; the information concerns the French reference product.
Uses
METHOTREXATE ACCORD is indicated for:
· The treatment of active rheumatoid arthritis in adult patients.
· The treatment of severe forms of psoriasis vulgaris, in particular plaque psoriasis, which cannot be adequately treated with conventional therapy, and active psoriatic arthritis in adults.
· Maintenance treatment in acute lymphoblastic leukemia (ALL) in adults, adolescents and children aged at least 3 years.
Driving
Methotrexate has a moderate influence on the ability to drive vehicles and use machines given that central nervous symptoms such as fatigue, dizziness or drowsiness may occur during treatment.
Hospital price
30,70 MAD
Commercial status
Non Commercialisé
Therapeutic class
RHUMATOLOGIE
References and update dates
AMMPS — catalogue marocain officiel · 2026-10-01
Product and price referenceBase de données publique des médicaments (France) · 2026-09-29 · Licence Ouverte
Read medical referenceThis information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.
Price history
Reference price recorded since 2026-10-01: 49,10 MAD
Reference price recorded since 2026-06-01: 49,10 MAD
Referenced presentations and strengths
Other strengths and forms
Routes and instructions may differ.
- LEDERTREXATE · 5 G · solution for injection · 1 bottle 200 ml
- LEDERTREXATE · 1 G · poudre pour solution injectable · box 1 bottle
- LEDERTREXATE · 50 MG · solution for injection · box of 1 bottle
- LEDERTREXATE · 50 MG · solution for injection · 1 bottle 2 ml
- METHOTREXATE BELLON · 25 MG · solution for injection · 1 bottle 1 ml
- METHOTREXATE BELLON · 5 MG · solution for injection · 1 bottle 2 ml
- METHOTREXATE BELLON · 5 MG / 2 ML · solution for injection · box of 1 bottle
- METHOTREXATE BELLON · 25 MG / ML · solution for injection · box of 1 bottle de 1 ml
- METHOTREXATE BELLON (H) · 500 MG · solution for injection · 10 bottle 20 ml
- METHOTREXATE BELLON (H) · 500 MG · solution for injection · 10 bottle 20 ml
- METHOTREXATE BIODIM · 5 MG · solution for injection · 1 bottle 2 ml
- METHOTREXATE BIODIM · 5 MG · solution for injection · 1 bottle 2 ml
